IMPROVE 2023: The 2nd International Meeting on Pathway‐Related Obesity: Vision & Evidence
Clinical Obesity · 2025
DOI: 10.1111/cob.70029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Obesity, 2025. Verfasst von Karine Clément und 19 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, Nutrition and Obesity: Systemic Approaches, NutriOmics, Research Unit, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: Bardet-Biedl Syndrome, Obesity, Receptor, Melanocortin, Type 4. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Rhythm Pharmaceuticals Inc.
Abstract (Originalsprache)
A total of 150 clinicians and researchers representing 19 countries came together in person and online to participate in the highly anticipated 2nd International Meeting on Pathway‐Related Obesity: Vision & Evidence (IMPROVE), held on 13–15 December 2023 in Paris, France. Building on the success of the inaugural event in 2022, this gathering served as a pivotal platform for attendees to delve into the latest scientific and clinical developments in hyperphagia and early‐onset obesity caused by rare melanocortin‐4 receptor (MC4R) pathway disease. The central objective of the meeting was to explore the complexities of MC4R pathway‐related diseases and generate opportunities for collaborative dialogue among delegates for the advancement of this field. The event unfolded across three distinct sessions, with a dedicated focus on monogenic MC4R pathway disease, Bardet‐Biedl syndrome (BBS) and hypothalamic obesity, together with a discussion on the future of the field. Additionally, the agenda featured three insightful workshops designed to facilitate in‐depth discussions. One workshop focused on the genetics of monogenic MC4R pathway diseases, another scrutinised the genetics of BBS and the final workshop examined patient management through the exploration of clinical cases. As we reflect on the wealth of information disseminated and the collaborative spirit that permeated the meeting, it becomes clear that IMPROVE 2023 was not merely an assembly of professionals; it was a forum where the future of research in rare MC4R pathway diseases and patient care took centre stage. Here, we encapsulate the key insights, discussions, and initiatives that emerged from this important meeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM, Nutrition and Obesity: Systemic Approaches, NutriOmics, Research Unit, Sorbonne Université, Paris, France.
- Assistance Publique-Hôpitaux de Paris, Nutrition Department, Pitié-Salpêtrière Hospital, Paris, France.
- Department of Paediatrics, Erasmus University Rotterdam, Rotterdam, the Netherlands.
- Department of Paediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Research Institute La Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
- CIBER 'Fisiopatología de la obesidad y nutrición' (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
- IMDEA Food Institute, Madrid, Spain.
Förderung
- Rhythm Pharmaceuticals Inc
Zitieren
APA
Clément, K., van den Akker, E. L. T., Argente, J., Beales, P., Cetiner, M., Dubern, B., Farooqi, S., Gouronc, A., Kühnen, P., Le Beyec, J., Lebreton, L., Meeker, D., Müller, H. L., Muller, J., Poitou, C., Sleiman, P., Vaisse, C., Wabitsch, M., Young, J., & Dollfus, H. (2025). IMPROVE 2023: The 2nd International Meeting on Pathway‐Related Obesity: Vision & Evidence. Clinical Obesity. https://doi.org/10.1111/cob.70029
Vancouver
Clément K, van den Akker ELT, Argente J, Beales P, Cetiner M, Dubern B, et al. IMPROVE 2023: The 2nd International Meeting on Pathway‐Related Obesity: Vision & Evidence. Clinical Obesity. 2025. doi:10.1111/cob.70029
BibTeX
@article{Clment2025,
author = {Clément, Karine and van den Akker, Erica L T and Argente, Jesús and Beales, Phil and Cetiner, Metin and Dubern, Béatrice and Farooqi, Sadaf and Gouronc, Aurélie and Kühnen, Peter and Le Beyec, Johanne and Lebreton, Louis and Meeker, David and Müller, Hermann L and Muller, Jean and Poitou, Christine and Sleiman, Patrick and Vaisse, Christian and Wabitsch, Martin and Young, Jacques and Dollfus, Hélène},
title = {IMPROVE 2023: The 2nd International Meeting on Pathway‐Related Obesity: Vision & Evidence},
journal = {Clinical Obesity},
year = {2025},
doi = {10.1111/cob.70029}
}
EUVIMED